Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYEyePoint Pharmaceuticals Announces U.S. Commercial Launch of DEXYCU (dexamethasone intraocular suspension) 9%PREV STORYAptose Reports Results for the Fourth Quarter and Year Ended December 31, 2018